Syn01 0003 01
This is a description of a prescription drug called SYNAGIS® used for intramuscular injection only. It contains Palivizumab, a humanized monoclonal antibody used to treat Respiratory Syncytial Virus (RSV) infections. Each vial contains 50mg of Palivizumab per 0.5ml of solution, along with histidine, glycine, and chloride. The medicine does not contain preservatives, and the unused portion should be discarded. The recommended dose is 15mg/kg intramuscularly, and a doctor's prescription is required to use the drug.*